Erythropoietin (EPO)
FDA APPROVED
Extensively Studied
Metabolic
Erythropoietin (EPO)
0
Amino acids
Molecular weight
Peptide
Type
Erythropoietin (EPO) is an essential glycoprotein hormone that stimulates red blood cell production. Naturally produced by the kidneys in response to low oxygen levels, recombinant human EPO is FDA-approved for treating anemia in chronic kidney disease and chemotherapy patients. EPO binding to receptors on bone marrow cells promotes survival and maturation of red blood cell precursors, increasing oxygen-carrying capacity. Due to performance-enhancing effects, it is banned in competitive sports.
Top researched benefits
Overview of Erythropoietin (EPO)
EPO binds to erythropoietin receptors (EPOR) on erythroid progenitor cells in bone marrow, activating three interconnected signaling pathways: JAK2/STAT5, PI3K/AKT, and RAS/MAPK. This promotes survival of red blood cell precursors by protecting them from apoptosis, accelerates proliferation and differentiation of erythroid cells, and increases hemoglobin production. Under hypoxic stress, endogenous EPO production can increase up to 1000-fold, demonstrating the body's powerful oxygen-sensing regulatory system.
Medical Indications Fdaapproved
- Primary FDA-approved indication for anemia secondary to chronic kidney disease.
- FDA-approved for treating anemia in cancer patients receiving chemotherapy.
- Used to reduce need for blood transfusions in certain surgical settings.
Performance Banned In Sports
- Increases oxygen delivery to muscles, improving endurance capacity. Banned by WADA.
- May accelerate adaptation to high altitude by increasing red blood cell mass.
Storage
2-8°C refrigerated; do not freeze; do not shake vials or syringes
Frequency
1-3 times weekly depending on response
Typical Dose
50-300 IU/kg based on medical indication
Cycle Duration
Variable - ongoing medical therapy adjusted based on hemoglobin levels
No visual available
Due to this peptide having no amino acids, there is no molecular chain to display.
Chemical Makeup
Key benefits
Stimulates red blood cell production
Increases oxygen-carrying capacity
FDA-approved for anemia treatment
Improves endurance capacity
Supports patients with chronic kidney disease
Helps chemotherapy-induced anemia
Well-characterized mechanism of action
Extensively studied safety profile
Community interest
This peptide is still gaining traction in the community.
EPO | Red Blood Cell Stimulating Hormone
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesErythropoietin (EPO) Molecular Information
View the scientifc details of Erythropoietin (EPO).
Molecular Weight
30DaChain Length
0Amino AcidsType
PeptideErythropoietin (EPO) Protocols
EPO is administered via subcutaneous or intravenous injection. Medical use requires prescription and monitoring. Dosing is individualized based on hemoglobin levels, with targets typically kept below 11-12 g/dL to minimize cardiovascular risks.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| CKD Anemia (medical) | 50 | 3 week range | SubQ or IV |
| Chemotherapy Anemia (medical) | 150 | 3 week range | SubQ |
| Maintenance (medical) | — | 1 week range | SubQ |
Reconstitution Instructions
Materials needed:
Steps to reconstitute
- Most EPO comes in pre-filled syringes
- Allow to reach room temperature before injection
- Inject subcutaneously or intravenously as directed
- Do not shake vials or syringes
Erythropoietin (EPO) Cycle
The Erythropoietin (EPO) Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Day 1-3
- Bone marrow stimulation begins
- Week 1-2
- Reticulocyte count increases
- Week 2-4
- Hemoglobin begins rising
- Week 4-12
- Target hemoglobin achieved with proper dosing
Dosing tools
Erythropoietin (EPO) Peptide Dosage Calculator
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Injection Results
Based on your vial and dilution inputs.
Safe concentration range
Erythropoietin (EPO)
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Erythropoietin (EPO) vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Reference Guide
Dosing Cycle
- Peptide
- Erythropoietin (EPO)
- Dosing
- 50-300 IU/kg based on medical indication
- Dosing Frequency
- 1-3 times weekly depending on response
- Cycle Duration
- Variable - ongoing medical therapy adjusted based on hemoglobin levels
- Storage
- 2-8°C refrigerated; do not freeze; do not shake vials or syringes
Note: Triple agonist; microdose for fewer side effects
Reconstitution Tips
- Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
- Inject water slowly — aim down the vial wall, not directly onto powder
- Never shake — gently swirl or roll the vial until dissolved
- Store properly — refrigerate at 2-8°C after reconstitution
- Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
- Keep sterile — always clean vial tops with alcohol before drawing
Peptide Interactions
Research suggestions of Erythropoietin (EPO) interactions with other common peptides and substances.
Side effects
Contraindications
Uncontrolled hypertension
Pure red cell aplasia history
Hemoglobin >12 g/dL (increased cardiovascular risk)
Active malignancy (relative contraindication)
Stop signs
Severe headache or vision changes
Chest pain or shortness of breath
Signs of blood clots (leg swelling, pain)
Sudden loss of response to EPO
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What benefits can peptides offer in research?
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
What are some exciting applications of peptides in modern science?
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
How do peptides influence health and wellness?
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Where can I find the latest studies on peptide applications?
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Are there any guidelines for using peptides in research?
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
What is the difference between peptides and proteins?
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
How should peptides be stored?
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Can peptides be taken orally?
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Erythropoietin (EPO)Research References
Erythropoietin (EPO) is an extensively studied compound
Erythropoietin (EPO)
Erythropoietin (EPO) is an extensively studied compound
Erythropoietin regulation of red blood cell production
Comprehensive review of EPO's oxygen-sensing mechanism and regulation of RBC production.
n.d.
Erythropoietin Stimulating Agents
FDA-approved indications include CKD anemia and chemotherapy-induced anemia. Risks increase when hemoglobin exceeds 11-12 g/dL.
n.d.
Erythropoiesis-stimulating agents and other methods to enhance oxygen transport
rHuEPO increases O2 supply to muscles and boosts performance in endurance sports.
n.d.
The mechanism of erythropoietin action
EPO promotes survival of erythroid progenitors by protecting from apoptosis.
n.d.